Emeprev (maropitant citrate) tablets

Emeprev Tablets for Dogs | Maropitant Citrate Anti-Nausea Emeprev (maropitant citrate) Tablets for Dogs are a prescription antiemetic medication used to help prevent and control vomiting in dogs, including vomiting associated with motion sickness and other causes. Formulated with the same active ingredient found in brand-name Cerenia®, Emeprev works by blocking substance P at the neurokinin-1 (NK1) receptor, helping to stop the vomiting reflex at its source. These tablets are commonly prescribed by veterinarians for both acute and chronic cases of vomiting and are suitable for use in dogs of appropriate age and weight as directed by a veterinarian. Emeprev tablets offer a reliable, cost-effective option for managing nausea and vomiting, helping dogs feel more comfortable during travel or illness. Indications: Emeprev (maropitant citrate) Tablets are indicated for the prevention of acute vomiting and the prevention of vomiting due to motion sickness in dogs. Key Benefits: Helps prevent and control vomiting in dogs Effective for motion sickness–related nausea Contains maropitant citrate, a veterinarian-trusted antiemetic Tablet form allows for accurate, convenient dosing Prescription-strength alternative to brand-name options What is Emeprev used for in dogs? Emeprev is prescribed to help prevent and treat vomiting in dogs, including vomiting caused by motion sickness and other conditions, as directed by a veterinarian. Is Emeprev the same as Cerenia? Emeprev contains maropitant citrate, the same active ingredient found in Cerenia, but may be offered as a more cost-effective alternative depending on availability. Dosage & Administration: For Prevention of Acute Vomiting For Prevention of Acute Vomiting in dogs 2-7 months of age: Administer Emeprev Tablets orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily for up to 5 consecutive days. For Prevention of Acute Vomiting in dogs 7 months of age and older: Administer Emeprev Tablets orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily until resolution of acute vomiting. If vomiting persists despite treatment, the case should be re-evaluated. Emeprev is most effective in preventing acute vomiting associated with chemotherapy if administered prior to the chemotherapeutic agent. For prevention of acute vomiting, dispense whole or half tablets in strength(s) that most closely result in a 3 mg/kg dose: Dog Body Weight Number of Tablets Pounds Kilograms 16 mg 24 mg 160 mg 8 4 ½ 15 8 1 25 12 1 50 24 2 65 30 1 130 60 2 Interchangeable use with Maropitant Citrate Injectable Solution for Prevention of Acute Vomiting: In dogs that are actively vomiting, to ensure that the full initial dose is administered, maropitant citrate injectable solution is recommended at a dose of 1 mg/kg once daily. (See package insert for maropitant citrate injectable solution.) Thereafter, for the prevention of acute vomiting, Emeprev Tablets at a dose of 2 mg/kg once daily may be used interchangeably with maropitant citrate injectable solution for up to 5 days. For Prevention of Vomiting Due to Motion Sickness in dogs 4 months and older For Prevention of Vomiting due to motion sickness in dogs 4 months of age and older: Administer Emeprev Tablets orally at a minimum dose of 8 mg/kg (3.6 mg/lb) body weight once daily for up to consecutive days. Administer Emeprev Tablets a minimum of two hours prior to travel with a small amount of food to mitigate vomiting associated with administration of the dose on empty stomach; however, refrain from feeding in a full meal prior to travel. Prevention of Vomiting Due to Motion Sickness in Dogs 4 months of age and older: Dispense whole or half tablets in strengths that most closely result in an 8 mg/kg dose once daily for up to 2 consecutive days: Dog Body Weight Number of Tablets Pounds Kilograms 16 mg 24 mg 60 mg 160 mg 2 1 ½ 3 1.5 ½ 4 2 1 6 3 1 8 4 2 13 6 2 16 7.5 1 22 10 ½ 33 15 2 44 20 1 66 30 1 ½ 88 40 2 132 60 3 Maropitant citrate injectable solution should not be used interchangeably with Emeprev Tablets for the prevention of vomiting due to motion sickness (8 mg/kg). Warnings: Not for use in humans. Keep out of the reach of children. In case of accidental ingestion, seek medical advice. Topical exposure may elicit localized allergic skin reactions in some individuals. Repeated or prolonged exposure may lead to skin sensitization. Wash hands with soap and water after administering drug. Emeprev is also an ocular irritant. In case of accidental eye exposure, flush with water for 15 minutes and seek medical attention. In puppies younger than 11 weeks of age, histological evidence of bone marrow hypocellularity was observed at higher frequency and greater severity in puppies treated with maropitant citrate compared to control puppies. In puppies 16 weeks and older, bone marrow hypocellularity was not observed. Keep Emeprev Tablets in a secure location of of reach of dogs, cats, and other animals to prevent accidental ingestion or overdose. Precautions: The safe use of Emeprev Tablets has not been evaluated in dogs used for breeding, or in pregnant or lactating bitches. The safe use of Emeprev has not been evaluated in dogs with gastrointestinal obstruction, or dogs that have ingested toxins Use with caution in dogs with hepatic dysfunction because maropitant citrate is metabolized by CYP3A enzymes. Use with caution with other medications that are highly protein bound. The concomitant use of Emeprev with other protein bound drugs has not been studied in dogs. Commonly used protein bound drugs include NSAIDs, cardiac, anticonvulsant, and behavioral medications. The influence of concomitant drugs that may inhibit the metabolism of Emeprev has not been ecaluated. Drug compatibility should be monitored in patients requiring adjunctive therapy. Maropitanmt citrate causes dose related decreases in appetite and body weight. To maximize therapeutic potential of Emeprev, the undelying cause of vomiting should be identified and addressed in dogs receiving Emeprev. Storage Conditions: Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° and 30°C (59° and 86°F). Shipping & Returns Shipping: For more information on our flexible shipping options, visit our Shipping Policies. Returns: For assistance with returns or replacements, review our Refund Policy. FAQ What is Emeprev (maropitant citrate) for dogs? Emeprev is a prescription medication containing maropitant citrate, used to prevent vomiting and motion sickness in dogs by blocking nausea signals in the brain. What conditions does Emeprev treat in dogs? Emeprev is commonly prescribed to prevent acute vomiting, manage nausea caused by illness or medications, and prevent motion sickness in dogs. How does maropitant citrate work in dogs? Maropitant citrate works by blocking neurokinin-1 (NK1) receptors in the brain, which stops the vomiting reflex before it starts. Is Emeprev safe for dogs? Yes, Emeprev is FDA-approved for dogs and is safe when used as prescribed by a veterinarian. Always follow dosing instructions carefully. Can Emeprev be used for motion sickness in dogs? Yes, Emeprev is highly effective for preventing motion sickness and should be given at least one hour before travel. How quickly does Emeprev start working? Emeprev typically begins working within 1 hour of administration and provides up to 24 hours of anti-nausea protection.